LY6G6D and colorectal carcinoma: A very recent article describes the presence of LY6G6D by immunohistochemistry (IHC) in MSS CRC with a total of 107 primary samples the overall prevalence of LY6G6D expression was 74% (IHC 1þ/2þ/3þ), with moderate to strong LY6G6D expression (IHC 2þ/3þ) in 25% of the cases [14].